Увійти

Готові списки джерел за темами / Arthritis Molecular aspects

Добірка наукової літератури з теми "Arthritis Molecular aspects"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 31 січня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Arthritis Molecular aspects".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Зміст

Статті в журналах
Дисертації
Книги
Частини книг

Статті в журналах з теми "Arthritis Molecular aspects":

1

Gross, D. M., and B. T. Huber. "Cellular and molecular aspects of Lyme arthritis." Cellular and Molecular Life Sciences 57, no. 11 (October 2000): 1562–69. http://dx.doi.org/10.1007/pl00000641.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Chetina, E. V., and E. P. Sharapova. "Rheumatic pain management: molecular aspects." Modern Rheumatology Journal 14, no. 1 (March 22, 2020): 93–100. http://dx.doi.org/10.14412/1996-7012-2020-1-93-100.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Rheumatic diseases (RDs), including osteoarthritis and rheumatoid arthritis, are non-infectious slowly progressive incurable inflammatory diseases that lead to prolonged disability due to damage to the musculoskeletal system. Pain is a dominant symptom at any stage of these diseases, is directly related to joint functioning, and determines the quality of life in patients. Moreover, despite the significant successes of studying the role of inflammation and regulation of autoimmune processes, the pathogenetic mechanisms for the development and maintenance of pain in RDs are little investigated. The nociceptive mechanisms due to inflammation and/or joint structural impairment are involved in the development of rheumatic pain. In addition, the latter is also associated with impaired signaling in the nervous system and with psychological problems in patients.At the present stage, pain treatment includes non-pharmacological interventions, as well as the use of certain pharmacological agents, in particular opioids and narcotic drugs. However, despite significant successes in the design of drugs that relieve pain, at present, a significant proportion of patients with RDs still experience pain after therapy. When designing novel drugs for the treatment of pain, it is necessary to take into account the molecular mechanisms of its development in RDs. This review considers the features of the manifestations of pain, its molecular markers and mechanisms at different stages of the disease in patients with the two most common RDs, such as rheumatoid arthritis and osteoarthritis.

3

Neeck, Gunther, Rainer Renkawitz, and Martin Eggert. "Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis." Cytokines, Cellular & Molecular Therapy 7, no. 2 (January 2002): 61–69. http://dx.doi.org/10.1080/13684730412331302081.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Kobayashi, Shu, Shigeki Momohara, Naoyuki Kamatani, and Hiroshi Okamoto. "Molecular aspects of rheumatoid arthritis: role of environmental factors." FEBS Journal 275, no. 18 (July 25, 2008): 4456–62. http://dx.doi.org/10.1111/j.1742-4658.2008.06581.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Okamoto, Hiroshi, Thomas P. Cujec, Hisashi Yamanaka, and Naoyuki Kamatani. "Molecular aspects of rheumatoid arthritis: role of transcription factors." FEBS Journal 275, no. 18 (July 25, 2008): 4463–70. http://dx.doi.org/10.1111/j.1742-4658.2008.06582.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

García-Hernández, Mariana H., Roberto González-Amaro, and Diana Patricia Portales-Pérez. "Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects." Immunotherapy 6, no. 5 (May 2014): 623–36. http://dx.doi.org/10.2217/imt.14.26.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Lotz, M., and J. Roudier. "Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects." Rheumatology International 9, no. 3-5 (November 1989): 147–52. http://dx.doi.org/10.1007/bf00271872.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Sacre, Sandra M., Evangelos Andreakos, Peter Taylor, Marc Feldmann, and Brian M. Foxwell. "Molecular therapeutic targets in rheumatoid arthritis." Expert Reviews in Molecular Medicine 7, no. 16 (August 24, 2005): 1–20. http://dx.doi.org/10.1017/s1462399405009488.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

In an attempt to combat the pain and damage generated by rheumatoid arthritis (RA), new drugs are being developed to target molecular aspects of the disease process. Recently, a major development has been the use of biologicals (antibodies and soluble receptors) that neutralise the activity of tumour necrosis factor α (TNF-α) and interleukin 1 (IL-1), both of which are involved in disease progression. An increase in our understanding of cell and molecular biology has resulted in the identification and investigation of potential new targets, and also the refinement and improvement of current therapeutic modalities. This review describes therapies that are approved, in clinical trials or under pre-clinical investigation at the laboratory level, particularly focusing on cytokines, although other therapeutic targets of interest are mentioned.

9

RULLI, NESTOR E., JULIAN MELTON, ANJA WILMES, GARY EWART, and SURESH MAHALINGAM. "The Molecular and Cellular Aspects of Arthritis Due to Alphavirus Infections." Annals of the New York Academy of Sciences 1102, no. 1 (April 2007): 96–108. http://dx.doi.org/10.1196/annals.1408.007.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Okamoto, Hiroshi. "Molecular aspects of rheumatoid arthritis: chemokines, environmental factors and transcription factors." FEBS Journal 275, no. 18 (July 25, 2008): 4447. http://dx.doi.org/10.1111/j.1742-4658.2008.06579.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Arthritis Molecular aspects":

1

Law, Wai-han, and 羅慧嫺. "Molecular mechanisms of arsenic trioxide in an in vitro model of rheumatoid arthritis synoviocyte." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41508531.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Connolly, Ashley Rex. "Cytokine gene expression in a rat model of polyarthritis /." Title page, contents and abstract only, 1998. http://web4.library.adelaide.edu.au/theses/09PH/09phc75238.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Olive, Colleen. "Molecular characterisation of the T-cell receptors expressed in rheumatoid arthritis patients." Phd thesis, 1993. http://hdl.handle.net/1885/143110.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Brasted, Melissa. "Effector CD4Ê T lymphocytes in the prodrome of polyarthritis." 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phb8239.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Connolly, Ashley Rex. "Cytokine gene expression in a rat model of polyarthritis / by Ashley Rex Connolly." Thesis, 1998. http://hdl.handle.net/2440/19176.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Bibliography: leaves 199-233.
xvii, 233 leaves : ill. ; 30 cm.
Describes the development of a method used for quantification of cytokine mRNA expression and its application to measuring changes in cytokine expression in the synovial tissue and lymph notes draining the hind feet of rats with adjuvant arthritis (AA).
Thesis (Ph.D.)--University of Adelaide, Dept. of Medicine, 1998

6

Roberts-Thomson, Peter J. "Low molecular weight IgM in health and disease / by Peter John Roberts-Thomson." 1987. http://hdl.handle.net/2440/38410.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

x, 156 leaves :
Title page, contents and abstract only. The complete thesis in print form is available from the University Library.
Thesis (M.D.)--University of Adelaide, Dept. of Medicine, 1988

7

Roberts-Thomson, Peter J. "Low molecular weight IgM in health and disease / by Peter John Roberts-Thomson." Thesis, 1987. http://hdl.handle.net/2440/38410.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Arthritis Molecular aspects":

1

Brewer, Jonathan Douglas. The coronary cure: A modified Mediterranean diet for the prevention of atherosclerosis, hypertension, obesity, diabetes, arthritis, and kidney stones : molecular mechanisms and practical guidelines : nutrition 101. [United States?]: J.D. Brewer, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Tsokos, George C. Principles of Molecular Rheumatology (Current Molecular Medicine). Humana Press, 2000.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

P, Cope Andrew, ed. Arthritis research: Methods and protocols. Totowa, N.J: Humana Press, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Cope, Andrew P. Arthritis Research: Volume 1: Methods and Protocols (Methods in Molecular Medicine). Humana Press, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Cope, Andrew P. Arthritis Research: Volume 2: Methods and Protocols (Methods in Molecular Medicine). Humana Press, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Arthritis research: Methods and protocols. Totowa, NJ: Humana Press, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Cope, Andrew P. Arthritis Research : Volume 1: Methods and Protocols. Humana Press, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Cope, Andrew P. Arthritis Research : Volume 2: Methods and Protocols. Humana Press, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Arthritis Molecular aspects":

1

Gay, S., and R. E. Gay. "Pathology of Rheumatoid Arthritis: Molecular and Inflammatory Aspects." In Symposium in Immunology VIII, 199–203. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59947-7_13.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Winchester, Robert. "MAPPING SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS INTO A CONFORMATIONALLY EQUIVALENT REGION OF MHC CLASS II MOLECULES ENCODED BY DIFFERENT ALLELES." In The Molecular Aspects of Autoimmunity, 241–63. Elsevier, 1990. http://dx.doi.org/10.1016/b978-0-12-249040-8.50021-3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Ege, Ferhat. "Pathogenesis, Pathology and Genetics of Osteoarthritis." In Rheumatoid Arthritis [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.99238.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Osteoarthritis (OA) is a condition with high prevalence worldwide. OA affects not only the articular cartilage, but the entire joint, including the subchondral bone, ligaments, capsule, synovial membrane and the periarticular muscles. Despite the fact that the risks associated with OA increase with age, it is not a part of the natural aging process. It typically involves the knee, hip, spine, hand and foot joints. Several factors play an important role in the pathogenesis of OA, including biomechanical factors, proinflammatory mediators and proteases. On the other hand, it was mostly the results of the studies conducted on the genetic, genomic and epigenetic aspects of OA, from among many of its underlying etiological factors, which shed light on the molecular processes involved in the etiopathogenesis of OA. As the mechanisms that cause joint tissue damage in OA come to light, the treatment of OA will go beyond just providing symptomatic relief. Consequentially, new treatments will emerge that will either slow or completely stop the progression of OA.